In vitro blood-brain barrier models for drug research: state-of-the-art and new perspectives on reconstituting these models on artificial basement membrane platforms.
暂无分享,去创建一个
[1] R. Keep,et al. Brain Endothelial Cell-Cell Junctions: How to “Open” the Blood Brain Barrier , 2008, Current neuropharmacology.
[2] Y. Kanai,et al. Localization of Ang-1, -2, Tie-2, and VEGF expression at endothelial-pericyte interdigitation in rat angiogenesis , 2006, Laboratory Investigation.
[3] Maxime Culot,et al. A Stable and Reproducible Human Blood-Brain Barrier Model Derived from Hematopoietic Stem Cells , 2014, PloS one.
[4] H. Gutmann,et al. Evaluation of the immortalized human brain capillary endothelial cell line BB19 as a human cell culture model for the blood–brain barrier , 2005, Brain Research.
[5] H. Wolburg,et al. Agrin, Aquaporin-4, and Astrocyte Polarity as an Important Feature of the Blood-Brain Barrier , 2009, The Neuroscientist.
[6] R. Liddington. Mapping out the basement membrane , 2001, Nature Structural Biology.
[7] A. Yu,et al. Claudins and the modulation of tight junction permeability. , 2013, Physiological reviews.
[8] A. Traweger,et al. “You Shall Not Pass”—tight junctions of the blood brain barrier , 2014, Front. Neurosci..
[9] A. D'emanuele,et al. Delivery of paclitaxel across cellular barriers using a dendrimer-based nanocarrier. , 2013, International journal of pharmaceutics.
[10] Dóra Hantosi,et al. Blood-brain barrier co-culture models to study nanoparticle penetration: focus on co-culture systems , 2015 .
[11] Nanoparticulate flurbiprofen reduces amyloid-β42 generation in an in vitro blood–brain barrier model , 2013, Alzheimer's Research & Therapy.
[12] B. Långström,et al. Species Differences in Blood-Brain Barrier Transport of Three Positron Emission Tomography Radioligands with Emphasis on P-Glycoprotein Transport , 2009, Drug Metabolism and Disposition.
[13] Stanley E. Lazic,et al. Transcriptional Profiling of Human Brain Endothelial Cells Reveals Key Properties Crucial for Predictive In Vitro Blood-Brain Barrier Models , 2012, PloS one.
[14] H. Galla,et al. The impact of pericytes on the blood-brain barrier integrity depends critically on the pericyte differentiation stage. , 2011, The international journal of biochemistry & cell biology.
[15] V. Teichberg,et al. Closing the gap between the in-vivo and in-vitro blood–brain barrier tightness , 2009, Brain Research.
[16] Arne Fischmann,et al. Extracellular matrix and the blood-brain barrier in glioblastoma multiforme: spatial segregation of tenascin and agrin , 2002, Acta Neuropathologica.
[17] Marcus J. Drake,et al. The Validation of a Functional, Isolated Pig Bladder Model for Physiological Experimentation , 2012, Front. Pharmacol..
[18] E. Hansson,et al. Astrocyte–endothelial interactions at the blood–brain barrier , 2006, Nature Reviews Neuroscience.
[19] S. Johansson,et al. Assembly of Laminin Polymers Is Dependent on β1-Integrins , 2001 .
[20] G. Bix,et al. Perlecan and the Blood-Brain Barrier: Beneficial Proteolysis? , 2012, Front. Pharmacol..
[21] W. Hsieh,et al. Effects of surface modification of PLGA-PEG-PLGA nanoparticles on loperamide delivery efficiency across the blood–brain barrier , 2013, Journal of biomaterials applications.
[22] C. Schwerk,et al. Culture models to study leukocyte trafficking across the choroid plexus , 2013, Fluids and Barriers of the CNS.
[23] Y. Kuo,et al. Targeting delivery of saquinavir to the brain using 83-14 monoclonal antibody-grafted solid lipid nanoparticles. , 2013, Biomaterials.
[24] G. D. del Zoppo,et al. Interendothelial Claudin-5 Expression Depends on Cerebral Endothelial Cell–Matrix Adhesion by β1-Integrins , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[25] Emma East,et al. A versatile 3D culture model facilitates monitoring of astrocytes undergoing reactive gliosis , 2009, Journal of tissue engineering and regenerative medicine.
[26] Kelvin H. Lee,et al. Membrane configuration optimization for a murine in vitro blood–brain barrier model , 2013, Journal of Neuroscience Methods.
[27] Yu Cao,et al. Cell-Culture Models of the Blood–Brain Barrier , 2014, Stroke.
[28] J. Greenwood,et al. Blood‐brain barrier‐specific properties of a human adult brain endothelial cell line , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[29] T. Terasaki,et al. Exogenous expression of claudin‐5 induces barrier properties in cultured rat brain capillary endothelial cells , 2007, Journal of cellular physiology.
[30] Hong Ding,et al. MMP-9 gene silencing by a quantum dot–siRNA nanoplex delivery to maintain the integrity of the blood brain barrier , 2009, Brain Research.
[31] M Gumbleton,et al. Progress and limitations in the use of in vitro cell cultures to serve as a permeability screen for the blood-brain barrier. , 2001, Journal of pharmaceutical sciences.
[32] Luca Cucullo,et al. In vitro blood-brain barrier models: current and perspective technologies. , 2012, Journal of pharmaceutical sciences.
[33] T. Kanda,et al. Establishment and characterization of spinal cord microvascular endothelial cell lines , 2013 .
[34] L. Rubin,et al. A cell culture model of the blood-brain barrier , 1991, The Journal of cell biology.
[35] S. Rapoport,et al. Cerebrovascular Permeability Coefficients to Sodium, Potassium, and Chloride , 1986, Journal of neurochemistry.
[36] Andreas Reichel,et al. An overview of in vitro techniques for blood-brain barrier studies. , 2003, Methods in molecular medicine.
[37] Masami Niwa,et al. Permeability Studies on In Vitro Blood–Brain Barrier Models: Physiology, Pathology, and Pharmacology , 2005, Cellular and Molecular Neurobiology.
[38] William Shain,et al. An endothelial and astrocyte co-culture model of the blood-brain barrier utilizing an ultra-thin, nanofabricated silicon nitride membrane. , 2005, Lab on a chip.
[39] Edward J. Rapp,et al. Immortalized Human Brain Endothelial Cells and Flow-Based Vascular Modeling: A Marriage of Convenience for Rational Neurovascular Studies , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[40] R. Kalluri. Basement membranes: structure, assembly and role in tumour angiogenesis , 2003, Nature reviews. Cancer.
[41] Yan Zhang,et al. Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[42] Z. Nagy,et al. Tight junctions of brain endothelium in vitro are enhanced by astroglia , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[43] K. Plate,et al. Wnt/β-catenin signaling controls development of the blood–brain barrier , 2008, The Journal of cell biology.
[44] Joachim Wegener,et al. The impact of glia-derived extracellular matrices on the barrier function of cerebral endothelial cells: an in vitro study. , 2007, Experimental cell research.
[45] M. Gumbleton,et al. Primary porcine brain microvascular endothelial cells: Biochemical and functional characterisation as a model for drug transport and targeting , 2007, Journal of drug targeting.
[46] S. Saxena,et al. Targeted Brain Derived Neurotropic Factors (BDNF) Delivery across the Blood-Brain Barrier for Neuro-Protection Using Magnetic Nano Carriers: An In-Vitro Study , 2013, PloS one.
[47] A. McMahon,et al. Wnt family proteins are secreted and associated with the cell surface. , 1993, Molecular biology of the cell.
[48] Edward J. Rapp,et al. Side by side comparison between dynamic versus static models of blood–brain barrier in vitro: A permeability study , 2006, Brain Research.
[49] G. Grau,et al. Platelets Potentiate Brain Endothelial Alterations Induced by Plasmodium falciparum , 2006, Infection and Immunity.
[50] M. Corada,et al. The molecular basis of the blood brain barrier differentiation and maintenance. Is it still a mystery? , 2011, Pharmacological research.
[51] Hanseup Kim,et al. Characterization of a microfluidic in vitro model of the blood-brain barrier (μBBB). , 2012, Lab on a chip.
[52] Rongqin Huang,et al. A leptin derived 30-amino-acid peptide modified pegylated poly-L-lysine dendrigraft for brain targeted gene delivery. , 2010, Biomaterials.
[53] Calvin J Kuo,et al. Wnt/β-catenin signaling is required for CNS, but not non-CNS, angiogenesis , 2009, Proceedings of the National Academy of Sciences.
[54] W. Haefeli,et al. NKIM-6, a new immortalized human brain capillary endothelial cell line with conserved endothelial characteristics , 2007, Cell and Tissue Research.
[55] P. Couraud,et al. Tight junctions at the blood brain barrier: physiological architecture and disease-associated dysregulation , 2012, Fluids and Barriers of the CNS.
[56] Eric V Shusta,et al. In vitro models of the blood–brain barrier: An overview of commonly used brain endothelial cell culture models and guidelines for their use , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[57] T. Tilling,et al. Basement Membrane Proteins Influence Brain Capillary Endothelial Barrier Function In Vitro , 1998, Journal of neurochemistry.
[58] Y. Kuo,et al. Solid lipid nanoparticles carrying chemotherapeutic drug across the blood–brain barrier through insulin receptor-mediated pathway , 2013, Journal of drug targeting.
[59] W. Risau,et al. Modulation of tight junction structure in blood-brain barrier endothelial cells. Effects of tissue culture, second messengers and cocultured astrocytes. , 1994, Journal of cell science.
[60] Michael L Shuler,et al. Murine in vitro model of the blood-brain barrier for evaluating drug transport. , 2011, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[61] L. Fenart,et al. Evaluation of effect of charge and lipid coating on ability of 60-nm nanoparticles to cross an in vitro model of the blood-brain barrier. , 1999, The Journal of pharmacology and experimental therapeutics.
[62] J. Brillault,et al. Lessons from CADASIL , 2002, Annals of the New York Academy of Sciences.
[63] P. Couraud,et al. The hCMEC/D3 cell line as a model of the human blood brain barrier , 2013, Fluids and Barriers of the CNS.
[64] P. Searson,et al. Influence of Basement Membrane Proteins and Endothelial Cell-Derived Factors on the Morphology of Human Fetal-Derived Astrocytes in 2D , 2014, PloS one.
[65] Luca Cucullo,et al. Development of a Humanized In Vitro Blood–Brain Barrier Model to Screen for Brain Penetration of Antiepileptic Drugs , 2007, Epilepsia.
[66] S. Strickland,et al. Astrocytic laminin regulates pericyte differentiation and maintains blood brain barrier integrity , 2014, Nature Communications.
[67] K. Hynynen,et al. Noninvasive and targeted drug delivery to the brain using focused ultrasound. , 2013, ACS chemical neuroscience.
[68] D. Stepensky,et al. Delivery of proteins to the brain by bolaamphiphilic nano-sized vesicles. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[69] F. Smedts,et al. Bioengineering of living renal membranes consisting of hierarchical, bioactive supramolecular meshes and human tubular cells. , 2011, Biomaterials.
[70] F. Charron,et al. The Hedgehog Pathway Promotes Blood-Brain Barrier Integrity and CNS Immune Quiescence , 2011, Science.
[71] M. Deli. Blood-brain barrier models , 2007 .
[72] T. Tsuruo,et al. Brain pericytes contribute to the induction and up-regulation of blood–brain barrier functions through transforming growth factor-β production , 2005, Brain Research.
[73] Xin-guo Jiang,et al. Study and evaluation of mechanisms of dual targeting drug delivery system with tumor microenvironment assays compared with normal assays. , 2014, Acta biomaterialia.
[74] J. Berwick,et al. LRP-1-mediated intracellular antibody delivery to the Central Nervous System , 2015, Scientific Reports.
[75] Á. Kittel,et al. A new blood–brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes , 2009, Neurochemistry International.
[76] J. Toldi,et al. Preparation and properties of nanoscale containers for biomedical application in drug delivery: preliminary studies with kynurenic acid , 2012, Journal of Neural Transmission.
[77] Kosuke Saito,et al. Establishment of a new conditionally immortalized cell line from human brain microvascular endothelial cells: A promising tool for human blood–brain barrier studies , 2012, Brain Research.
[78] W. Banks,et al. From blood–brain barrier to blood–brain interface: new opportunities for CNS drug delivery , 2016, Nature Reviews Drug Discovery.
[79] U. Bickel,et al. How to measure drug transport across the blood-brain barrier , 2011, NeuroRX.
[80] K. M. Baeten,et al. Extracellular matrix and matrix receptors in blood–brain barrier formation and stroke , 2011, Developmental neurobiology.
[81] T. Terasaki,et al. A pericyte‐derived angiopoietin‐1 multimeric complex induces occludin gene expression in brain capillary endothelial cells through Tie‐2 activation in vitro , 2004, Journal of neurochemistry.
[82] Hong Yuan,et al. Brain-targeting study of stearic acid–grafted chitosan micelle drug-delivery system , 2012, International journal of nanomedicine.
[83] J. Hubbell,et al. Molecularly Engineered Self‐Assembling Membranes for Cell‐Mediated Degradation , 2015, Advanced healthcare materials.
[84] Oliver Distler,et al. Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis , 2012, Nature Communications.
[85] Y. Kuo,et al. Transcytosis of CRM197-grafted polybutylcyanoacrylate nanoparticles for delivering zidovudine across human brain-microvascular endothelial cells. , 2012, Colloids and surfaces. B, Biointerfaces.
[86] V. Weaver,et al. Extracellular matrix assembly: a multiscale deconstruction , 2014, Nature Reviews Molecular Cell Biology.
[87] B. Engelhardt,et al. The blood–brain and the blood–cerebrospinal fluid barriers: function and dysfunction , 2009, Seminars in Immunopathology.
[88] C. Capobianco,et al. An intimate interplay between precocious, migrating pericytes and endothelial cells governs human fetal brain angiogenesis , 2007, Angiogenesis.
[89] Maxime Culot,et al. Modelling of the blood–brain barrier in drug discovery and development , 2007, Nature Reviews Drug Discovery.
[90] A. Prat,et al. Glial influence on the Blood Brain Barrier , 2013, Glia.
[91] T. Nagai,et al. Transport of nerve growth factor encapsulated into liposomes across the blood-brain barrier: in vitro and in vivo studies. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[92] Luca Cucullo,et al. The role of shear stress in Blood-Brain Barrier endothelial physiology , 2011, BMC Neuroscience.
[93] T. Kanda,et al. Establishment of a new conditionally immortalized human brain microvascular endothelial cell line retaining an in vivo blood–brain barrier function , 2010, Journal of cellular physiology.
[94] O. Ogunshola,et al. Cell‐specific blood–brain barrier regulation in health and disease: a focus on hypoxia , 2014, British journal of pharmacology.
[95] Rui L Reis,et al. Self-assembly in nature: using the principles of nature to create complex nanobiomaterials. , 2013, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[96] L. Kaczmarek,et al. Tissue inhibitor of matrix metalloproteinases-1 loaded poly(lactic-co-glycolic acid) nanoparticles for delivery across the blood–brain barrier , 2014 .
[97] P Delorme,et al. An Easier, Reproducible, and Mass‐Production Method to Study the Blood–Brain Barrier In Vitro , 1990, Journal of neurochemistry.
[98] J. Pachter,et al. Where is the blood–brain barrier … really? , 2005, Journal of neuroscience research.
[99] Peter C. Searson,et al. The blood-brain barrier: an engineering perspective , 2013, Front. Neuroeng..
[100] I. Wilhelm,et al. In vitro models of the blood-brain barrier for the study of drug delivery to the brain. , 2014, Molecular pharmaceutics.
[101] C. Betsholtz,et al. Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. , 2011, Developmental cell.
[102] Sean P. Palecek,et al. A retinoic acid-enhanced, multicellular human blood-brain barrier model derived from stem cell sources , 2014, Scientific Reports.
[103] M. Dehouck,et al. Adapting coculture in vitro models of the blood–brain barrier for use in cancer research: maintaining an appropriate endothelial monolayer for the assessment of transendothelial migration , 2016, Laboratory Investigation.
[104] N. Abbott. Dynamics of CNS Barriers: Evolution, Differentiation, and Modulation , 2005, Cellular and Molecular Neurobiology.
[105] Xiaoyu Xu,et al. A Novel Brain Neurovascular Unit Model with Neurons, Astrocytes and Microvascular Endothelial Cells of Rat , 2013, International journal of biological sciences.
[106] Te-Wei Lee,et al. In Vitro and in Vivo Evaluation of Lactoferrin-Conjugated Liposomes as a Novel Carrier to Improve the Brain Delivery , 2013, International journal of molecular sciences.
[107] M. Masserini,et al. Functionalization of liposomes with ApoE-derived peptides at different density affects cellular uptake and drug transport across a blood-brain barrier model. , 2011, Nanomedicine : nanotechnology, biology, and medicine.
[108] Qiang Zhang,et al. Monitoring the transport of polymeric micelles across MDCK cell monolayer and exploring related mechanisms. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[109] J M Scherrmann,et al. Drug delivery to brain via the blood-brain barrier. , 2002, Vascular pharmacology.
[110] Ignacio A. Romero,et al. Development of a three-dimensional, all-human in vitro model of the blood–brain barrier using mono-, co-, and tri-cultivation Transwell models , 2011, Journal of Neuroscience Methods.
[111] N J Abbott,et al. Electrical resistance across the blood‐brain barrier in anaesthetized rats: a developmental study. , 1990, The Journal of physiology.
[112] M. Dehouck,et al. Stem Cell-Based Human Blood-Brain Barrier Models for Drug Discovery and Delivery. , 2016, Trends in biotechnology.
[113] Kelvin H. Lee,et al. Optimization of endothelial cell growth in a murine in vitro blood–brain barrier model , 2011, Biotechnology journal.
[114] L. Fenart,et al. Contribution of glial cells and pericytes to the mRNA profiles of P-glycoprotein and multidrug resistance-associated proteins in an in vitro model of the blood–brain barrier , 2004, Brain Research.
[115] P Couvreur,et al. Puromycin‐based purification of rat brain capillary endothelial cell cultures. Effect on the expression of blood–brain barrier‐specific properties , 2005, Journal of neurochemistry.
[116] H. von Briesen,et al. Nanoparticulate Transport of Oximes over an In Vitro Blood-Brain Barrier Model , 2010, PloS one.
[117] R. Uzbekov,et al. Modelling the neurovascular unit and the blood-brain barrier with the unique function of pericytes. , 2011, Current neurovascular research.
[118] M. Niemi,et al. Membrane transporters in drug development , 2010, Nature Reviews Drug Discovery.
[119] L. Fenart,et al. Amyloid-β peptides, Alzheimer's disease and the blood-brain barrier. , 2013, Current Alzheimer research.
[120] P. Gaillard,et al. Enhanced brain drug delivery: safely crossing the blood-brain barrier. , 2012, Drug discovery today. Technologies.
[121] Yan Zhang,et al. Cationic albumin-conjugated pegylated nanoparticles as novel drug carrier for brain delivery. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[122] S. Liebner,et al. In vitro models of the blood-brain barrier. , 2014, Methods in molecular biology.
[123] N. Abbott,et al. Astrocyte–endothelial interactions and blood–brain barrier permeability * , 2002 .
[124] B. Barres,et al. Pericytes are required for blood–brain barrier integrity during embryogenesis , 2010, Nature.
[125] G. Bezakova,et al. New insights into the roles of agrin , 2003, Nature Reviews Molecular Cell Biology.
[126] M. Osanai,et al. Tight junction proteins claudin-2 and -12 are critical for vitamin D-dependent Ca2+ absorption between enterocytes. , 2008, Molecular biology of the cell.
[127] P. Couraud,et al. Expression and localization of claudins-3 and -12 in transformed human brain endothelium , 2012, Fluids and Barriers of the CNS.
[128] J. Hartgerink,et al. Self-assembly of peptide-amphiphile nanofibers: the roles of hydrogen bonding and amphiphilic packing. , 2006, Journal of the American Chemical Society.
[129] S. Krähenbühl,et al. The human brain endothelial cell line hCMEC/D3 as a human blood‐brain barrier model for drug transport studies , 2008, Journal of neurochemistry.
[130] B. Engelhardt,et al. Localization of claudin-3 in tight junctions of the blood-brain barrier is selectively lost during experimental autoimmune encephalomyelitis and human glioblastoma multiforme , 2003, Acta Neuropathologica.
[131] Yan Li,et al. A dual-targeting nanocarrier based on poly(amidoamine) dendrimers conjugated with transferrin and tamoxifen for treating brain gliomas. , 2012, Biomaterials.
[132] D. Bergles,et al. Human astrocytes develop physiological morphology and remain quiescent in a novel 3D matrix. , 2015, Biomaterials.
[133] Y. Kuo,et al. Methylmethacrylate-sulfopropylmethacrylate nanoparticles with surface RMP-7 for targeting delivery of antiretroviral drugs across the blood-brain barrier. , 2012, Colloids and surfaces. B, Biointerfaces.
[134] A. Moses,et al. Comparative study of four immortalized human brain capillary endothelial cell lines, hCMEC/D3, hBMEC, TY10, and BB19, and optimization of culture conditions, for an in vitro blood–brain barrier model for drug permeability studies , 2013, Fluids and Barriers of the CNS.
[135] N. Rothwell,et al. An immortalised astrocyte cell line maintains the in vivo phenotype of a primary porcine in vitro blood–brain barrier model , 2012, Brain Research.
[136] P. Couraud,et al. Differential effects of hydrocortisone and TNFα on tight junction proteins in an in vitro model of the human blood–brain barrier , 2008, The Journal of physiology.
[137] P. Couraud,et al. ABC and SLC transporter expression and proton oligopeptide transporter (POT) mediated permeation across the human blood--brain barrier cell line, hCMEC/D3 [corrected]. , 2010, Molecular pharmaceutics.
[138] K. Hayashi,et al. Pericytes from Brain Microvessels Strengthen the Barrier Integrity in Primary Cultures of Rat Brain Endothelial Cells , 2007, Cellular and Molecular Neurobiology.
[139] C. Catania,et al. Neurons and ECM regulate occludin localization in brain endothelial cells , 2000, Neuroreport.
[140] R. Janzer,et al. Astrocytes induce blood–brain barrier properties in endothelial cells , 1987, Nature.
[141] B. Engelhardt,et al. Endothelial Cell Laminin Isoforms, Laminins 8 and 10, Play Decisive Roles in T Cell Recruitment across the Blood–Brain Barrier in Experimental Autoimmune Encephalomyelitis , 2001, The Journal of cell biology.
[142] M. Mayberg,et al. A new dynamic in vitro model for the multidimensional study of astrocyte–endothelial cell interactions at the blood–brain barrier , 2002, Brain Research.
[143] Gilberto Alves,et al. Blood-brain barrier models and their relevance for a successful development of CNS drug delivery systems: a review. , 2014, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[144] A. Berg,et al. BBB ON CHIP: microfluidic platform to mechanically and biochemically modulate blood-brain barrier function , 2013, Biomedical microdevices.
[145] E. Hohenester,et al. Laminins in basement membrane assembly , 2013, Cell adhesion & migration.
[146] P. Couraud,et al. Instruction of Circulating Endothelial Progenitors In Vitro towards Specialized Blood-Brain Barrier and Arterial Phenotypes , 2014, PloS one.
[147] J. Cryan,et al. Nanoparticles and the Blood-Brain Barrier: Advancing from In-Vitro Models Towards Therapeutic Significance , 2014, Pharmaceutical Research.
[148] Maria Antfolk,et al. In Vitro Blood-Brain Barrier Models-An Overview of Established Models and New Microfluidic Approaches. , 2015, Journal of pharmaceutical sciences.
[149] S. Tsukita,et al. Size-selective loosening of the blood-brain barrier in claudin-5–deficient mice , 2003, The Journal of cell biology.
[150] I. Sherman,et al. Studies of Plasmodium falciparum cytoadherence using immortalized human brain capillary endothelial cells. , 1996, International journal for parasitology.
[151] Á. Kittel,et al. Comparison of brain capillary endothelial cell-based and epithelial (MDCK-MDR1, Caco-2, and VB-Caco-2) cell-based surrogate blood-brain barrier penetration models. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[152] Lihong Liu,et al. Modern methods for delivery of drugs across the blood-brain barrier. , 2012, Advanced drug delivery reviews.
[153] Sean P. Palecek,et al. Human Blood-Brain Barrier Endothelial Cells Derived from Pluripotent Stem Cells , 2012, Nature Biotechnology.
[154] D. Begley,et al. Direct Evidence That Polysorbate-80-Coated Poly(Butylcyanoacrylate) Nanoparticles Deliver Drugs to the CNS via Specific Mechanisms Requiring Prior Binding of Drug to the Nanoparticles , 2003, Pharmaceutical Research.
[155] F. Orsenigo,et al. Endothelial adherens junctions control tight junctions by VE-cadherin-mediated upregulation of claudin-5 , 2008, Nature Cell Biology.